Who Holds Tempest Therapeutics, Inc. (TPST)? 20 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 20 holders, $1 million in total.
Largest holders
The 20 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 511,286 | $567,527 | +2763% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 233,888 | $259,616 | +0% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 86,625 | $96,155 | 0% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 68,908 | $76,488 | +0% | 13F |
| BlackRock, Inc. | 39,068 | $43,365 | +0% | 13F |
| Squarepoint Ops LLC | 30,900 | $34,299 | New | 13F |
| NORTHERN TRUST CORP | 20,136 | $22,351 | +43% | 13F |
| CITADEL ADVISORS LLC | 19,820 | $22,000 | New | 13F |
| UBS Group AG | 5,636 | $6,255 | +24% | 13F |
| Tower Research Capital LLC (TRC) | 3,922 | $4,353 | +41% | 13F |
| MORGAN STANLEY | 2,022 | $2,244 | -2% | 13F |
| OSAIC HOLDINGS, INC. | 1,513 | $1,669 | -1% | 13F |
| Federation des caisses Desjardins du Quebec | 292 | $324 | +0% | 13F |
| JONES FINANCIAL COMPANIES LLLP | 239 | $258 | +0% | 13F |
| BARCLAYS PLC | 222 | $246 | New | 13F |
| SBI Securities Co., Ltd. | 56 | $62 | +0% | 13F |
| Parallel Advisors, LLC | 18 | $20 | +0% | 13F |
| Caitong International Asset Management Co., Ltd | 3 | $3 | New | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 3 | $3 | +0% | 13F |
| ROYAL BANK OF CANADA | 28 | $0 | +4% | 13F |
Questions and answers
- How many institutions hold Tempest Therapeutics, Inc.?
- 20 managers reported Tempest Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 21 the quarter before.
- Who is the largest institutional holder of Tempest Therapeutics, Inc.?
- SABBY MANAGEMENT, LLC, with 511,286 shares worth $567,527 on its 13F for Q2 2026.
- How many institutions bought or sold out of Tempest Therapeutics, Inc. in Q2 2026?
- 4 managers reported a new position and 5 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Tempest Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/tempest-therapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.